Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Mesoblast Limited ( (AU:MSB) ) just unveiled an update.
Mesoblast Limited has announced that JPMorgan Chase & Co. and its affiliates have ceased to be substantial holders in the company as of June 11, 2025. This change in substantial holding involves various transactions and securities lending agreements managed by JPMorgan’s subsidiaries, impacting the voting securities of Mesoblast Limited. The cessation of JPMorgan’s substantial holding could influence Mesoblast’s shareholder dynamics and market perception.
The most recent analyst rating on (AU:MSB) stock is a Buy with a A$1.10 price target. To see the full list of analyst forecasts on Mesoblast Limited stock, see the AU:MSB Stock Forecast page.
More about Mesoblast Limited
YTD Price Performance: -42.10%
Average Trading Volume: 6,082,418
Technical Sentiment Signal: Buy
Current Market Cap: A$2.29B
Find detailed analytics on MSB stock on TipRanks’ Stock Analysis page.